BCI-137
CAS No. 112170-24-8
BCI-137( BCI 137 | BCI137 )
Catalog No. M27752 CAS No. 112170-24-8
BCI-137 is an Argonaute 2 ligand. It acts by targeting the MicroRNA Binding Domain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 272 | In Stock |
|
| 10MG | 402 | In Stock |
|
| 25MG | 664 | In Stock |
|
| 50MG | 888 | In Stock |
|
| 100MG | 1242 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBCI-137
-
NoteResearch use only, not for human use.
-
Brief DescriptionBCI-137 is an Argonaute 2 ligand. It acts by targeting the MicroRNA Binding Domain.
-
DescriptionBCI-137 is an Argonaute 2 ligand. It acts by targeting the MicroRNA Binding Domain.
-
In Vitro——
-
In Vivo——
-
SynonymsBCI 137 | BCI137
-
PathwayOthers
-
TargetOther Targets
-
RecptorLPS-TLR4/MD2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number112170-24-8
-
Formula Weight313.28
-
Molecular FormulaC11H11N3O6S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (319.19 mM)
-
SMILESCC(NS(=O)(=O)c1ccc2[nH]c(=O)c(=O)[nH]c2c1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yi Wang, et al. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2. J Pharmacol Exp Ther. 2015 Jun;353(3):539-50
molnova catalog
related products
-
Isoflurane
Isoflurane is a stable, non-explosive inhalation anesthetic that has been reported to induce caspase-3 activation.
-
RPR107393 free base
RPR107393 free base is a selective inhibitor of squalene synthase [rat liver microsomal squalene synthase] with an IC50 of 0.8 nM.
-
Clorsulon
Clorsulon is used in the treatment of Fasciola hepatica infections in calves and sheep.
Cart
sales@molnova.com